Data Control Key In Applying Electronic Health Records As Clinical Trial Tool, FDA Says

Newly finalized guidance from US FDA details the agency's considerations for device and drug sponsors to rely on electronic health records as a clinical trial data source.

Electronic health records (EHRs) are a promising source of data for clinical trials, US FDA says, but study sponsors can't be lax about document control when relying on hospital-owned patient-record systems.

The agency issued guidance July 18 to describe important considerations for using EHRs to collect real-world data to support FDA approvals of devices, drugs and biologics. It finalizes a...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D